Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
695M
-
Number of holders
-
295
-
Total 13F shares, excl. options
-
546M
-
Shares change
-
+18.6M
-
Total reported value, excl. options
-
$5.77B
-
Value change
-
+$197M
-
Put/Call ratio
-
1.17
-
Number of buys
-
163
-
Number of sells
-
-108
-
Price
-
$10.57
Significant Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) as of Q2 2024
333 filings reported holding ROIV - Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share as of Q2 2024.
Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) has 295 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 546M shares
of 695M outstanding shares and own 78.55% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (71.4M shares), VIKING GLOBAL INVESTORS LP (69.2M shares), QVT Financial LP (66.7M shares), FMR LLC (46.6M shares), BlackRock Inc. (35.4M shares), MORGAN STANLEY (29.3M shares), Rubric Capital Management LP (23M shares), STATE STREET CORP (18.4M shares), Patient Square Capital LP (12.2M shares), and Two Seas Capital LP (10.3M shares).
This table shows the top 295 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.